Cardiogen 20mg – 10 vials

Cardiogen (Ala-Glu-Asp-Arg) is a tetrapeptide bioregulator originally developed by the St Petersburg Institute of Bioregulation and Gerontology. It belongs to a class of short-chain peptide bioregulators known as cytomedins, which are thought to interact with DNA and regulate gene expression in a tissue-specific manner. Cardiogen demonstrates selective affinity for cardiac muscle tissue, making it a subject of considerable interest in cardiovascular and gerontological research.

In preclinical studies, Cardiogen has been investigated for its potential to modulate cardiomyocyte function, support myocardial cell homeostasis, and attenuate age-related deterioration of cardiac tissue. Researchers have explored its cytoprotective properties in models of cardiac stress, ischaemia, and cellular senescence. Its short amino acid sequence — just four residues — is thought to facilitate efficient cellular uptake and interaction with nuclear structures involved in transcriptional regulation.

This 20mg research-grade supply is presented as a lyophilised powder with a purity exceeding 98%, ensuring reliability and consistency across experimental protocols. Molecular formula: C₁₄H₂₄N₆O₉. Molecular weight: 436.37 g/mol. CAS number: 142438-04-8.

Recommended storage: −20°C, protected from light and moisture. Reconstitute in sterile bacteriostatic water or an appropriate solvent prior to use.

For research purposes only. Not for human use.